Fibonacci Retracements Explained: How to Spot Key Reversal Levels in 2026 Read what the experts are trading this weekExclusive analysis from FXEmpire top analysts — curated insights you won't find on ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Jan. 14, 2025 A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Blood tests can’t confirm multiple sclerosis (MS), but they help rule out other conditions with similar symptoms like Lyme disease, lupus, anemia, thyroid disease, and vitamin deficiencies. Doctors ...

James Chen, CMT is an expert trader, investment adviser, and global market strategist. Thomas J. Brock is a CFA and CPA with more than 20 years of experience in various areas including investing, ...

Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician (CMT). Katrina Ávila Munichiello is an experienced editor, writer, fact-checker, and ...